Dr. Reddy’s Research and Development BV-医療機器分野:企業M&A・提携分析

◆英語タイトル:Dr. Reddy’s Research and Development BV - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011151
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dr. Reddy’s Research and Development BV (Dr. Reddy’s Research and Development), a subsidiary of Dr. Reddy’s Laboratories Ltd is a drug formulation and manufacturing service provider that develops and manufactures improved injectable pharmaceuticals. The company offers services such as formulation development, process development, analytical development, process scale up, animal trial manufacturing, clinical trial manufacturing of products in vials, manufacturing release, clinical release and stability studies. It offers special formulation and manufacturing services in the areas of protein and peptide formulations, freeze drying, liposomes, microspheres, solubilisation and emulsions. The company serves pharmaceutical and biotechnology companies. Dr. Reddy’s Research and Development is headquartered in Leiden, the Netherlands.

Dr. Reddy’s Research and Development BV – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dr. Reddy’s Research and Development BV, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dr. Reddy’s Research and Development BV, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Dr. Reddy’s Research and Development BV, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dr. Reddy’s Research and Development BV, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Dr. Reddy’s Research and Development BV, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Dr. Reddy’s Research and Development BV, Medical Equipment, Deal Details 10
Equity Offering 10
Octoplus Completes First Tranche Of Private Placement Of Common Stock For US$1.6 Million 10
Octoplus Completes Private Placement Of Common Stock For US$5.5 Million 11
Acquisition 13
Dr Reddy’s Labs Acquires OctoPlus 13
Dr. Reddy’s Research and Development BV – Key Employees 15
Dr. Reddy’s Research and Development BV – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Legal and Regulatory 17
Jan 19, 2017: Dr. Reddy’s subsidiary OctoPlus is now ‘Dr. Reddy’s Research and Development B.V.’ 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Dr. Reddy’s Research and Development BV, Medical Equipment, Key Facts 2
Dr. Reddy’s Research and Development BV, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Dr. Reddy’s Research and Development BV, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dr. Reddy’s Research and Development BV, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Dr. Reddy’s Research and Development BV, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dr. Reddy’s Research and Development BV, Deals By Market, 2011 to YTD 2017 8
Dr. Reddy’s Research and Development BV, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Octoplus Completes First Tranche Of Private Placement Of Common Stock For US$1.6 Million 10
Octoplus Completes Private Placement Of Common Stock For US$5.5 Million 11
Dr Reddy's Labs Acquires OctoPlus 13
Dr. Reddy’s Research and Development BV, Key Employees 15

★海外企業調査レポート[Dr. Reddy’s Research and Development BV-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carr’s Group Plc (CARR):企業の財務・戦略的SWOT分析
    Carr's Group Plc (CARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Roka Bioscience Inc:医療機器:M&Aディール及び事業提携情報
    Summary Roka Bioscience Inc (Roka) is a manufacturer and distributor of molecular assays and instruments for food safety industry. The company offers products such as Atlas- automated molecular pathogen detection system, the listeria LSP detection assay, listeria monocytogenes Lmg2 detection assay, …
  • BrainCool AB (BRAIN):企業の製品パイプライン分析2018
    Summary BrainCool AB (BrainCool), a subsidiary of Dignitana AB, is a medical device company that focuses on developing, and commercializing medical cooling systems for brain cooling and pain management. The company’s products are based on the principle that applying therapeutic hypothermia contribut …
  • Pilot Energy Ltd (PGY):企業の財務・戦略的SWOT分析
    Summary Pilot Energy Ltd (Pilot), formerly known as Rampart Energy Ltd, is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in Australia. Its projects include Australia EP416 and EP480, Australia WA-481-P, and Australia EP …
  • CFF GmbH & Co KG :企業の戦略・SWOT・財務情報
    CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Oil and Natural Gas Corporation Ltd (ONGC)-エネルギー分野:企業M&A・提携分析
    Summary Oil and Natural Gas Corporation Ltd (ONGC) is an integrated oil and gas company. It explores for and produces oil and natural gas; refines crude oil; and markets and distributes petroleum products. The company's product portfolio includes crude oil, natural gas, liquefied natural gas, naphth …
  • Choppies Enterprises Limited (CHOPPIES):企業の財務・戦略的SWOT分析
    Choppies Enterprises Limited (CHOPPIES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • 1-800-FLOWERS.COM, Inc.:企業の戦略・SWOT・財務分析
    1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report Summary 1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary MDU Resources Group, Inc. (MDU) is an energy, and construction materials and services company. It mines aggregates and markets crushed stone, sand, gravel and related construction materials. The …
  • Ferno-Washington Inc:企業の戦略的SWOT分析
    Ferno-Washington Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Cara Therapeutics Inc (CARA):企業の財務・戦略的SWOT分析
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruritus. Its lead product candidate includes …
  • SciClone Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SciClone Pharmaceuticals Inc (SciClone), a subsidiary of Silver Biotech Investment Ltd, develops and commercializes products for the treatment of cancer, cardiovascular disorders and infectious diseases. The company’s lead product, Zadaxin (thymalfasin) is an immunostimulatory agent indicate …
  • Ashland Global Holdings Inc (ASH):企業の財務・戦略的SWOT分析
    Ashland Global Holdings Inc (ASH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Foundation Medicine Inc (FMI):企業の財務・戦略的SWOT分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd, is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne …
  • IOOF Holdings Ltd (IFL):企業の財務・戦略的SWOT分析
    IOOF Holdings Ltd (IFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • MallInckrodt Plc (MNK):企業の財務・戦略的SWOT分析
    MallInckrodt Plc (MNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Avery Dennison Corporation (AVY):医療機器:M&Aディール及び事業提携情報
    Summary Avery Dennison Corporation (Avery Dennison) is a labeling and packaging materials and solutions provider. The company produces pressure-sensitive materials, tags, labels, tickets, and other converted products. It also manufactures and sells fasteners, tickets, tags, RFID inlays and tags, and …
  • BankUnited Inc:企業の戦略・SWOT・財務情報
    BankUnited Inc - Strategy, SWOT and Corporate Finance Report Summary BankUnited Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cable & Wireless Communications Ltd:企業の戦略的SWOT分析
    Cable & Wireless Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • GigaGen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary GigaGen Inc (GigaGen) is a pre-clinical biotherapeutics company that develops antibody therapies to treat diseases of immune dysregulation. The company discovers and develops monoclonal and polyclonal antibody therapies and T cell therapies derived from immune repertoires. Its single cell se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆